EAOO launches first strategic plan


The European Academy of Optometry and Optics (EAOO) has launched its first 3-year strategic plan for 2014 through 2016.

The European Academy of Optometry and Optics (EAOO) has launched its first 3-year strategic plan for 2014 through 2016. The Academy was originally launched in 2009, with plans to strengthen and develop its growing network of eye and vision care professionals across Europe in order to raise the standards and practice of optometry and optics.

Clinical practice, education and research development will be the three areas of focus for the Academy over the next 3 years, with the following objectives:

  • Clinical practice: to promote good clinical practice by members of the Academy and support their scope of practice.
  • Education: to promote excellence in optometric and optical education at the university and college level through the sharing of skills, knowledge and experience between professors, academic staff and students.
  • Research development: to encourage innovation in the development and application of research in optometry, optics and vision science in Europe.

Other objectives include communicating effectively with members, working towards financial sustainability and strengthening relationships with the European Council of Optometry and Optics (ECOO) and other strategic partners.

Paul Murphy, president of the EAOO, said: "It's nearly five years since the Academy was founded, and while a lot has been achieved, we are excited to be starting out on a new path that will bring further benefits to Academy members, and improvements to vision care across Europe. I'm delighted that the Academy has agreed its new 3-year strategic plan, which will guide us as we continue to expand our work."

To access the strategic plan, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.